These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 14702517)
21. The analysis by Manuel and colleagues creates controversy with headlines, not data. Genest J; McPherson R; Frohlich J; Fodor G CMAJ; 2005 Apr; 172(8):1033-4; discussion 1037. PubMed ID: 15824410 [No Abstract] [Full Text] [Related]
22. [Treatment of high blood cholesterol in patients with coronary heart disease]. Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661 [No Abstract] [Full Text] [Related]
23. [Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)]. Higashikata T Nihon Rinsho; 2004 Mar; 62 Suppl 3():628-36. PubMed ID: 15171447 [No Abstract] [Full Text] [Related]
27. [Pathogenesis and prophylaxis of arteriosclerosis]. Müller F; Wenzel G Z Gesamte Inn Med; 1969 Jan; 24(1):25-8. PubMed ID: 5784085 [No Abstract] [Full Text] [Related]
28. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]
29. The management of hypercholesterolemia revisited. Wiggins BS Manag Care Interface; 2001 Jan; 14(1):58-66, 72. PubMed ID: 11214536 [TBL] [Abstract][Full Text] [Related]
30. [Hyperlipidemia in the elderly]. Kawano M Nihon Rinsho; 2002 May; 60(5):1017-23. PubMed ID: 12029980 [TBL] [Abstract][Full Text] [Related]
32. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
33. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Aronow WS; Ahn C; Kronzon I; Goldman ME Am J Cardiol; 2001 Sep; 88(6):693-5. PubMed ID: 11564402 [No Abstract] [Full Text] [Related]
34. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view. Crouch MA J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369 [No Abstract] [Full Text] [Related]
35. Choice of lipid-regulating drugs. Med Lett Drugs Ther; 2001 May; 43(1105):43-8. PubMed ID: 11378632 [No Abstract] [Full Text] [Related]
36. [A new approach to the treatment of dyslipidemia]. Kevelaitiene S; Slapikas R Medicina (Kaunas); 2008; 44(5):407-13. PubMed ID: 18541958 [TBL] [Abstract][Full Text] [Related]
39. Eicosapentaenoic acid for prevention of major coronary events. Colhoun HM Lancet; 2007 Jul; 370(9583):215. PubMed ID: 17658384 [No Abstract] [Full Text] [Related]
40. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre. Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]